Stock Analysis on Net
AI Tokens
Stock Analysis on Net

Humana Inc. (NYSE:HUM)

This company has been moved to the archive! The financial data has not been updated since October 30, 2024.

Common-Size Income Statement
Quarterly Data

Humana Inc., common-size consolidated income statement (quarterly data)

Microsoft Excel
3 months ended: Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Premiums 96.20 96.24 96.38 96.03 96.11 96.31 96.24 95.49 94.88 94.29 94.73 94.06 95.92 97.60 97.74 97.43 97.64 97.63 97.74 97.92 97.56 97.80 97.78
Services 3.80 3.76 3.62 3.97 3.89 3.69 3.76 4.51 5.12 5.71 5.27 5.94 4.08 2.40 2.26 2.57 2.36 2.37 2.26 2.08 2.44 2.20 2.22
External revenues 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Investment income (loss) 1.18 1.02 0.98 1.12 1.18 1.04 0.73 0.72 0.76 0.20 0.01 -0.16 -0.16 0.86 0.38 1.14 3.69 0.41 0.79 0.93 0.84 0.71 0.63
Benefits -86.46 -85.63 -85.68 -87.06 -83.27 -83.14 -82.33 -83.41 -81.25 -80.88 -81.88 -82.69 -83.53 -83.78 -84.00 -86.02 -80.63 -74.58 -83.19 -84.79 -82.94 -82.56 -84.30
Operating costs -11.49 -10.77 -10.37 -14.62 -12.53 -11.75 -11.22 -15.94 -13.53 -13.44 -12.04 -16.10 -12.56 -10.34 -9.75 -16.28 -12.98 -12.39 -11.27 -13.19 -11.73 -10.56 -10.37
Depreciation and amortization -0.72 -0.72 -0.71 -0.77 -0.77 -0.72 -0.70 -0.82 -0.80 -0.74 -0.71 -0.76 -0.72 -0.70 -0.69 -0.67 -0.66 -0.63 -0.61 -0.71 -0.79 -0.68 -0.67
Operating expenses -98.67% -97.12% -96.77% -102.45% -96.56% -95.61% -94.25% -100.16% -95.58% -95.05% -94.63% -99.55% -96.81% -94.82% -94.44% -102.97% -94.27% -87.59% -95.08% -98.69% -95.45% -93.79% -95.34%
Income from operations 2.51% 3.90% 4.22% -1.33% 4.62% 5.42% 6.47% 0.56% 5.18% 5.15% 5.38% 0.29% 3.03% 6.04% 5.94% -1.84% 9.42% 12.81% 5.72% 2.24% 5.39% 6.91% 5.29%
Gain on sale of Gentiva Hospice 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.01 1.06 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Interest expense -0.58 -0.57 -0.54 -0.56 -0.44 -0.45 -0.43 -0.48 -0.45 -0.43 -0.38 -0.43 -0.42 -0.39 -0.33 -0.38 -0.39 -0.40 -0.32 -0.36 -0.38 -0.37 -0.39
Other income (expense), net 0.32 -0.19 -0.21 -0.37 0.02 -0.20 0.03 -0.38 -0.06 0.03 0.09 -0.14 5.29 -2.05 -0.56 -0.21 0.04 1.19 -1.58 1.79 0.51 1.08 -0.24
Income before income taxes and equity in net earnings (losses) 2.24% 3.14% 3.46% -2.26% 4.20% 4.77% 6.08% -0.32% 5.73% 4.75% 5.09% -0.28% 7.89% 3.61% 5.05% -2.43% 9.06% 13.61% 3.82% 3.67% 5.51% 7.62% 4.66%
Provision for income taxes -0.53 -0.76 -0.86 0.29 -0.98 -1.12 -1.35 0.26 -0.47 -1.81 -1.19 0.24 -0.58 -0.89 -1.13 0.94 -2.32 -4.12 -1.34 -0.49 -1.24 -1.87 -1.14
Equity in net earnings (losses) -0.06 -0.06 -0.08 -0.09 -0.05 -0.04 -0.06 -0.02 0.01 0.01 -0.02 -0.02 0.07 0.16 0.10 0.03 0.18 0.13 0.04 -0.01 0.01 0.07 0.02
Net income 1.65% 2.32% 2.52% -2.06% 3.18% 3.61% 4.66% -0.08% 5.27% 2.95% 3.88% -0.06% 7.39% 2.87% 4.02% -1.45% 6.92% 9.62% 2.52% 3.17% 4.28% 5.83% 3.54%
Net (income) loss attributable to noncontrolling interests 0.00 0.00 0.01 0.00 0.01 0.01 0.00 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net income attributable to Humana 1.65% 2.32% 2.53% -2.07% 3.19% 3.62% 4.67% -0.07% 5.28% 2.95% 3.88% -0.07% 7.39% 2.87% 4.02% -1.45% 6.92% 9.62% 2.52% 3.17% 4.28% 5.83% 3.54%

Based on: 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31).

The financial performance over the analyzed period is characterized by high revenue concentration in premiums and significant volatility in operating margins, particularly during fourth-quarter periods. While external revenues remain the baseline for the common-size analysis, the underlying cost structure demonstrates cyclical pressures that periodically compress net profitability.

Revenue Composition
Premiums constitute the vast majority of external revenues, typically ranging between 94% and 98%. A notable shift occurred between September 2021 and June 2022, where the proportion of premium revenue decreased to a low of 94.06%, while service-related revenues increased from approximately 2% to a peak of 5.94% in December 2021. Since 2023, the mix has stabilized, with premiums returning to approximately 96% and services settling around 3.6% to 3.8%.
Expense Analysis
Benefit costs represent the primary expenditure, fluctuating between 74.58% and 87.06% of external revenues. There is a discernible trend of increasing benefit costs in recent quarters, reaching 86.46% by September 2024. Operating costs exhibit significant seasonality, with marked spikes every December (e.g., 16.28% in December 2020, 16.10% in December 2021, and 15.94% in December 2022), suggesting recurring year-end administrative or operational burdens.
Operating and Net Profitability
Income from operations is highly volatile, with a peak of 12.81% in June 2020 contrasted by losses in December 2020 (-1.84%) and December 2023 (-1.33%). This volatility is mirrored in the net income attributable to the company, which has fluctuated from a high of 9.62% in June 2020 to a low of -2.07% in December 2023. The most recent data from September 2024 shows a net income margin of 1.65%, indicating a contraction compared to the historical averages seen in 2019 and 2021.
Investment and Non-Operating Items
Investment income has shown inconsistent patterns, ranging from a high of 3.69% in September 2020 to negative values in late 2021. More recently, it has stabilized between 0.98% and 1.18% of external revenues. Interest expenses have trended slightly upward over the long term, moving from approximately 0.39% in early 2019 to 0.58% by September 2024, reflecting a marginal increase in the cost of debt relative to revenue.

AI Ask an analyst for more

My previous chats

Add tokens

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.

How can I help you?